The token’s decline continues a downward trend, with resistance at $1,000-$1,008 and support at $972.85.Markets, AI Market Insights, BNB, Technical AnalysisRead More

You might also be interested in reading Royalty Pharma raises quarterly dividend by 5% to $0.22/share.